ACHIEVE LIFE SCIENCES, INC.
Last · NASDAQ$7.000.00 (0.00%)close · yahoo · 12h ago
Vol 1.64M ≈ 11.50M
MA10MA20MA50
Market cap$721.72M103.1M sh
P/E · TTM-4.1fwd -10.7 · eps -1.69 · loss
Beta2.31vs S&P 500
Div yield0.00%annual · TTM
52w range
$2.62$8.64
Volume1.6Msession
Issuer
Legal nameACHIEVE LIFE SCIENCES, INC.
HQUnited States (US)
ListingUS ACHV
ISINUS0044685008
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2835
CurrencyUSD
Entity registrylei:549300V82ZKZDTAU0A46
CIK0000949858
Websitewww.achievelifesciences.com
Employees28
AddressAchieve Life Sciences, Inc. 22722 29th Drive SE 98021, Bothell
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-03-24
From latest 10-K · 2026-03-24
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.4 years
- Accumulated Deficit High — Accumulated deficit / equity 1209%
Upcoming earnings
THU.5NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.19
Est. revenue
0
Earnings transcripts
Press & signals
- GlobeNewswire
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
- GlobeNewswire
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
- GlobeNewswire
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags
Showing 5 of 81 filings